These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 22652096)

  • 1. Incidence of isolated nodal failure in non-small cell lung cancer patients included in a prospective study of the value of PET-CT.
    Kolodziejczyk M; Bujko K; Michalski W; Kepka L
    Radiother Oncol; 2012 Jul; 104(1):58-61. PubMed ID: 22652096
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of [18F]fluorodeoxyglucose PET-CT staging on treatment planning in radiotherapy incorporating elective nodal irradiation for non-small-cell lung cancer: a prospective study.
    Kolodziejczyk M; Kepka L; Dziuk M; Zawadzka A; Szalus N; Gizewska A; Bujko K
    Int J Radiat Oncol Biol Phys; 2011 Jul; 80(4):1008-14. PubMed ID: 20656419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of isolated nodal failure for non-small cell lung cancer (NSCLC) treated with the elective nodal irradiation (ENI) using 3D-conformal radiotherapy (3D-CRT) techniques--a retrospective analysis.
    Kepka L; Bujko K; Zolciak-Siwinska A
    Acta Oncol; 2008; 47(1):95-103. PubMed ID: 17851862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of failure after postoperative radiotherapy for incompletely resected (R1) non-small cell lung cancer: implications for radiation target volume design.
    Olszyna-Serementa M; Socha J; Wierzchowski M; Kępka L
    Lung Cancer; 2013 May; 80(2):179-84. PubMed ID: 23395416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of incidental radiation dose to uninvolved mediastinal/supraclavicular lymph nodes in patients with limited-stage small cell lung cancer treated without elective nodal irradiation.
    Ahmed I; DeMarco M; Stevens CW; Fulp WJ; Dilling TJ
    Med Dosim; 2011; 36(4):440-7. PubMed ID: 21397488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Omission of elective node irradiation on basis of CT-scans in patients with limited disease small cell lung cancer: a phase II trial.
    De Ruysscher D; Bremer RH; Koppe F; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Pitz C; Simons J; ten Velde G; Dohmen J; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Dehing C; Pijls M; Minken A; Lambin P
    Radiother Oncol; 2006 Sep; 80(3):307-12. PubMed ID: 16949169
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidental irradiation of mediastinal and hilar lymph node stations during 3D-conformal radiotherapy for non-small cell lung cancer.
    Kepka L; Bujko K; Zolciak-Siwinska A; Garmol D
    Acta Oncol; 2008; 47(5):954-61. PubMed ID: 17899455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is involved-field radiotherapy based on CT safe for patients with limited-stage small-cell lung cancer?
    Xia B; Chen GY; Cai XW; Zhao JD; Yang HJ; Fan M; Zhao KL; Fu XL
    Radiother Oncol; 2012 Feb; 102(2):258-62. PubMed ID: 22056536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective mediastinal node irradiation based on FDG-PET scan data in patients with non-small-cell lung cancer: a prospective clinical study.
    De Ruysscher D; Wanders S; van Haren E; Hochstenbag M; Geeraedts W; Utama I; Simons J; Dohmen J; Rhami A; Buell U; Thimister P; Snoep G; Boersma L; Verschueren T; van Baardwijk A; Minken A; Bentzen SM; Lambin P
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):988-94. PubMed ID: 15989999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.
    Fernandes AT; Shen J; Finlay J; Mitra N; Evans T; Stevenson J; Langer C; Lin L; Hahn S; Glatstein E; Rengan R
    Radiother Oncol; 2010 May; 95(2):178-84. PubMed ID: 20356642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Outcome after PET-CT based radiotherapy for non-small cell lung cancer].
    Socha J; Kołodziejczyk M; Kępka L
    Pneumonol Alergol Pol; 2013; 81(1):30-9. PubMed ID: 23258469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer.
    Hoopes DJ; Tann M; Fletcher JW; Forquer JA; Lin PF; Lo SS; Timmerman RD; McGarry RC
    Lung Cancer; 2007 May; 56(2):229-34. PubMed ID: 17353064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
    Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
    J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omitting elective nodal irradiation during thoracic irradiation in limited-stage small cell lung cancer--evidence from a phase II trial.
    Colaco R; Sheikh H; Lorigan P; Blackhall F; Hulse P; Califano R; Ashcroft L; Taylor P; Thatcher N; Faivre-Finn C
    Lung Cancer; 2012 Apr; 76(1):72-7. PubMed ID: 22014897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET-CT use and the occurrence of elective nodal failure in involved field radiotherapy for non-small cell lung cancer: A systematic review.
    Kepka L; Socha J
    Radiother Oncol; 2015 May; 115(2):151-6. PubMed ID: 25892612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C; Sonmezoglu K; Toker A; Yilmazbayhan D; Dilege S; Halac M; Erelel M; Ece T; Mudun A
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 Non-small-cell lung cancer: a Leuven Lung Cancer Group Study.
    De Leyn P; Stroobants S; De Wever W; Lerut T; Coosemans W; Decker G; Nafteux P; Van Raemdonck D; Mortelmans L; Nackaerts K; Vansteenkiste J
    J Clin Oncol; 2006 Jul; 24(21):3333-9. PubMed ID: 16849747
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer.
    Miyasaka Y; Suzuki K; Takamochi K; Matsunaga T; Oh S
    Eur J Cardiothorac Surg; 2013 Jul; 44(1):83-7. PubMed ID: 23233074
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is mediastinoscopy still the gold standard to evaluate mediastinal lymph nodes in patients with non-small cell lung carcinoma?
    Sivrikoz CM; Ak I; Simsek FS; Döner E; Dündar E
    Thorac Cardiovasc Surg; 2012 Mar; 60(2):116-21. PubMed ID: 21692019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of treatment outcomes between involved-field and elective nodal irradiation in limited-stage small cell lung cancer.
    Han TJ; Kim HJ; Wu HG; Heo DS; Kim YW; Lee SH
    Jpn J Clin Oncol; 2012 Oct; 42(10):948-54. PubMed ID: 22811409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.